Lonza Group AG (LONN.SW)

Switzerland · Healthcare · CHF

Key financials

ROE: -3.19%; 2025 (actual)
ROA: -1.46%; 2025 (actual)
Gross Margin: 35.35%; 2025 (actual)
Net Margin: -4.21%; 2025 (actual)
Total Assets: CHF 17,907.00M; 2025 (actual)
Net Income: -CHF 275.00M; 2025 (actual)
Valuation: CHF 37,172.41M; 2025 (actual)
Stock Price: CHF 532.22; 2025 (actual)

Historical & projected performance

Reported figures and Equlion model projections for the next 5 years.

Metric	2025 (actual)	2026	2027	2028	2029	2030
ROE	-3.19%	-1.02%	-0.86%	-0.75%	-0.73%	-0.63%
Sector average	-19.57%	-18.86%	21.26%	45.9%	27.83%	13.61%
ROA	-1.46%	-0.45%	-0.37%	-0.31%	-0.28%	-0.24%
Sector average	-4.19%	-6.68%	-24.58%	1.77%	-29.44%	7.73%
Gross Margin	35.35%	35.35%	35.35%	35.35%

Amounts in CHF (millions); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2025. Projections are model estimates, not investment advice.

Want the full financial forecast report for Lonza Group AG? It covers the balance sheet, income statement and Equlion model projections.

Total Assets	CHF 17,907.00M	CHF 17,918.56M	CHF 18,629.62M	CHF 19,330.16M	CHF 20,016.89M	CHF 20,488.32M
Sector average	CHF 6,583.66M	CHF 7,029.78M	CHF 7,875.11M	CHF 8,842.33M	CHF 9,880.55M	CHF 10,888.36M

Net Income	-CHF 275.00M	-CHF 80.46M	-CHF 66.71M	-CHF 58.15M	-CHF 55.88M	-CHF 48.07M
Sector average	CHF 509.04M	CHF 497.74M	CHF 567.21M	CHF 655.95M	CHF 738.04M	CHF 795.14M

Valuation	CHF 37,172.41M	CHF 18,586.21M	CHF 15,411.64M	CHF 13,432.10M	CHF 12,908.32M	CHF 11,103.76M
Sector average	CHF 12,182.57M	CHF 13,169.96M	CHF 13,319.59M	CHF 13,502.66M	CHF 13,728.88M	CHF 13,908.08M

Stock Price	CHF 532.22	CHF 266.11	CHF 220.66	CHF 192.32	CHF 184.82	CHF 158.98
Sector average	CHF 102.74	CHF 98.77	CHF 102.59	CHF 107.21	CHF 112.19	CHF 115.32